Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) — Cash Flow Quality Index
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Cash Flow Quality Index of 2.15x as of December 2025. Operating cash flow of TL140.82 Million exceeds net income of TL65.61 Million, indicating high earnings quality where cash backs reported profits. Explore Meditera Tibbi Malzeme Sanayi ve Ticaret cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cash Flow Quality Index (2018–2024)
Historical Cash Flow Quality Index for Meditera Tibbi Malzeme Sanayi ve Ticaret AS across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Meditera Tibbi Malzeme Sanayi ve Ticaret reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2024)
Year-by-year earnings quality comparison for Meditera Tibbi Malzeme Sanayi ve Ticaret AS. For live market cap and the full company financial profile, see Meditera Tibbi Malzeme Sanayi ve Ticaret market capitalisation.
| Year | Quality Index | Operating CF (TRY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 8.12x | TL780.69 Million | TL96.11 Million | ▼ -62.1% |
| 2023 | 21.45x | TL801.02 Million | TL37.35 Million | ▲ +124822.4% |
| 2022 | 0.02x | TL5.10 Million | TL297.05 Million | ▼ -92.1% |
| 2021 | 0.22x | TL36.64 Million | TL167.70 Million | ▼ -82.0% |
| 2020 | 1.21x | TL73.26 Million | TL60.43 Million | ▼ -22.8% |
| 2019 | 1.57x | TL20.01 Million | TL12.73 Million | ▼ -73.2% |
| 2018 | 5.87x | TL73.26 Million | TL12.49 Million | — |